KINERET

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug KINERET contains one active pharmaceutical ingredient (API):

1	Recombinant human interleukin-1 receptor antagonist UNII 9013DUQ28K - ANAKINRA
	Anakinra neutralises the biologic activity of interleukin-1α (IL-1α) and interleukin-1β (IL-1β) by competitively inhibiting their binding to interleukin-1 type I receptor (IL-1RI). Interleukin-1 (IL-1) is a pivotal pro-inflammatory cytokine mediating many cellular responses including those important in synovial inflammation.
	Read more about Anakinra

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KINERET Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AC03	Anakinra	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors
Discover more medicines within L04AC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10263E, 10264F
CA	Health Products and Food Branch	02245913
EE	Ravimiamet	1198661, 1198728, 1198739, 1633799, 1633801, 1633812
ES	Centro de información online de medicamentos de la AEMPS	102203006
FI	Lääkealan turvallisuus- ja kehittämiskeskus	373254, 418642
FR	Base de données publique des médicaments	60663231
GB	Medicines & Healthcare Products Regulatory Agency	361080
IE	Health Products Regulatory Authority	88936
IL	מִשְׂרַד הַבְּרִיאוּת	6665
IT	Agenzia del Farmaco	035607011, 035607023, 035607035, 035607047, 035607050, 035607062, 035607074
LT	Valstybinė vaistų kontrolės tarnyba	1029083, 1029084, 1029085, 1074113, 1074114, 1074115
NL	Z-Index G-Standaard	15140237
NL	Z-Index G-Standaard, PRK	67385
PL	Rejestru Produktów Leczniczych	100126933
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53719001, W53719002, W53719003, W53720001
US	FDA, National Drug Code	66658-234